← Browse by Condition
Medical Condition

coronavirus disease covid 19

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06667700 Phase 3
Recruiting

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Enrollment
3,082 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC
View Trial →